SomaLogic

OverviewSuggest Edit

SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.

TypePrivate
Founded2000
HQBoulder, US
Websitesomalogic.com
Employee Ratings3.2

Latest Updates

Employees (est.) (Sept 2020)213
Cybersecurity ratingAMore

Key People/Management at SomaLogic

Larry Gold

Larry Gold

Chairman and Founder
Stephen A. Williams

Stephen A. Williams

Chief Medical Officer
Charles M. Lillis

Charles M. Lillis

Director
Nebojsa Janjic

Nebojsa Janjic

Chief Science Officer
Richard Post

Richard Post

Director
Terry L. Randall

Terry L. Randall

Director
Show more

SomaLogic Office Locations

SomaLogic has an office in Boulder
Boulder, US (HQ)
2945 Wilderness Pl
Show all (1)

SomaLogic Financials and Metrics

Summary Metrics

Founding Date

2000

SomaLogic total Funding

$541.5 m

SomaLogic latest funding size

$200 m

Time since last funding

3 years ago

SomaLogic investors

SomaLogic's latest funding round in January 2018 was reported to be $200 m. In total, SomaLogic has raised $541.5 m
Show all financial metrics

SomaLogic Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

SecurityScorecard logo

SomaLogic Online and Social Media Presence

Embed Graph

SomaLogic News and Updates

Agilent and SomaLogic Sign Agreement for Supply of Custom Microarrays

Use of Agilent's custom microarrays in the SOMAscan® assay will help drive biomarker discovery efforts as well as novel diagnostics and accelerated pharmaceutical development.read more

SomaLogic to Present at 37th Annual J. P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 2, 2019 /PRNewswire/ -- SomaLogic, Inc., announced today that its new Chief Executive Officer, Roy Smythe, M.D., will present the company's current status and strategic direction at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. Dr....

Roy Smythe, M.D., selected as next CEO of SomaLogic

BOULDER, Colo., Nov. 14, 2018 /PRNewswire/ -- The SomaLogic Board of Directors announced today that they have selected Roy Smythe, M.D. as the next Chief Executive Officer of SomaLogic. "As SomaLogic draws closer to our goal of being a global leader in health information, we must continue ...

Aptamers Market to Surge Past US$ 10,407 Million by 2025 due to Widened Application Area

Global Aptamers Market, By Type (Nucleic Acid Aptamers, Peptide Aptamers), Application (Diagnostics, Therapeutics, Research and Development), End User (Biotechnology and Pharmaceutical Companies, Contract Research Organization, Academic and Research Institutions), and Geography - Insights, Size, Sha…

SomaLogic Blogs

Somalogic and NEC Solution Innovators announce launch of Foneslife Corporation

SomaLogic, Inc. and NEC Solution Innovators, Ltd. of Japan, a subsidiary of NEC Corporation, announced today the establishment of FonesLife Corporation, a new Tokyo-based company that will bring a series of new clinical health management tests based on SomaLogic’s proprietary protein-measurement tec…

Will I be Mobile When I am Older?: Proteomics May Have the Answer

If not caught early, mobility loss is difficult to reverse (Leveille, Penninx, Melzer, Izmirlian, & Guralnik, 2000). Therefore, the sooner the onset of disability is found the better the chances of not losing one’s independence. But how far ahead of time can a future loss of mobility be seen? Th…

What Can Our Bodies Tell Us that Can Aid in Fighting COVID-19?

SARS-CoV-2 (the virus that causes COVID-19) is menacing. This is a given. But, how does it affect the body and cause all the problems we are seeing? The post What Can Our Bodies Tell Us that Can Aid in Fighting COVID-19? appeared first on SomaLogic.

Listen to This Message to Achieve Better Health

Genomics, transcriptomics, proteomics and metabolomics are all examples of the body’s many languages. Understanding these languages could open the door to new perspectives about what is happening in the body in real time and warn about health problems down the road. But which one (or combo) will be …

Statement on SomaLogic’s commitment to diversity by Roy Smythe, CEO

At SomaLogic, we measure proteins in the human body, and derive important health insights from that information for each individual. Depending on the day, the expression of these proteins in each individual human body can vary significantly, and we analyze this variability to discern patterns that m…

Chickens, Proteins & Your Health

What do you have in common with this chicken? Perplexed? So is the chicken. While the two of you may cross roads from time to time, the features that really bind the two of you together are proteins. The post Chickens, Proteins & Your Health appeared first on SomaLogic.
Show more

SomaLogic Frequently Asked Questions

  • When was SomaLogic founded?

    SomaLogic was founded in 2000.

  • Who are SomaLogic key executives?

    SomaLogic's key executives are Larry Gold, Stephen A. Williams and Charles M. Lillis.

  • How many employees does SomaLogic have?

    SomaLogic has 213 employees.

  • Who are SomaLogic competitors?

    Competitors of SomaLogic include Fyodor Biotechnologies, Otsuka Novel Products and Micropoint Bioscience.

  • Where is SomaLogic headquarters?

    SomaLogic headquarters is located at 2945 Wilderness Pl, Boulder.

  • Where are SomaLogic offices?

    SomaLogic has an office in Boulder.

  • How many offices does SomaLogic have?

    SomaLogic has 1 office.